A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
01 2021
Historique:
received: 23 02 2019
revised: 28 01 2020
accepted: 10 02 2020
pubmed: 7 6 2020
medline: 16 6 2021
entrez: 7 6 2020
Statut: ppublish

Résumé

Drivers at risk of sudden incapacitation from syncope pose a potential threat to themselves and to society. The purpose of this systematic review is to synthesize the risk of motor vehicle collisions (MVCs) for patients with a history of syncope. We systematically searched Medline (1946-2019) as well as Cinahl, Embase, Psychinfo, and the Transportation Research Information Documentation (1806-2017) for articles on MVCs and drivers with vasovagal syncope (VVS), arrhythmic syncope, or syncope not yet diagnosed (NYD). Quality ratings were assigned by team consensus. Eleven studies of moderate quality were included (n = 42,972). Compared with the general populations of Canada, the United States, and the United Kingdom (0.49%-2.29% per driver-year), the prospective MVC risk was lower for VVS (0.0%-0.31% per driver-year; 3 studies; n = 782) and higher for arrhythmic syncope (1.9%-3.4% per driver-year; 2 studies; n = 730). The results were more variable for syncope NYD (0.0%-6.9% per driver-year prospectively; 6 studies; n = 41,460). Patients with syncope NYD had an almost 2-fold increased MVC risk in the largest study, although the smaller studies showed contradictory findings. VVS patients appear to be at very low risk for MVCs, supporting current guidelines which do not recommend driving suspension for these patients in most cases. Although the data for other forms of syncope are too limited for definitive conclusions and must be improved, arrhythmic syncope appears to be associated with nontrivial risk.

Sections du résumé

BACKGROUND
Drivers at risk of sudden incapacitation from syncope pose a potential threat to themselves and to society. The purpose of this systematic review is to synthesize the risk of motor vehicle collisions (MVCs) for patients with a history of syncope.
METHODS
We systematically searched Medline (1946-2019) as well as Cinahl, Embase, Psychinfo, and the Transportation Research Information Documentation (1806-2017) for articles on MVCs and drivers with vasovagal syncope (VVS), arrhythmic syncope, or syncope not yet diagnosed (NYD). Quality ratings were assigned by team consensus.
RESULTS
Eleven studies of moderate quality were included (n = 42,972). Compared with the general populations of Canada, the United States, and the United Kingdom (0.49%-2.29% per driver-year), the prospective MVC risk was lower for VVS (0.0%-0.31% per driver-year; 3 studies; n = 782) and higher for arrhythmic syncope (1.9%-3.4% per driver-year; 2 studies; n = 730). The results were more variable for syncope NYD (0.0%-6.9% per driver-year prospectively; 6 studies; n = 41,460). Patients with syncope NYD had an almost 2-fold increased MVC risk in the largest study, although the smaller studies showed contradictory findings.
CONCLUSIONS
VVS patients appear to be at very low risk for MVCs, supporting current guidelines which do not recommend driving suspension for these patients in most cases. Although the data for other forms of syncope are too limited for definitive conclusions and must be improved, arrhythmic syncope appears to be associated with nontrivial risk.

Identifiants

pubmed: 32504546
pii: S0828-282X(20)30173-2
doi: 10.1016/j.cjca.2020.02.070
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-161

Informations de copyright

Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Justin N Chee (JN)

Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Safety Program Development Branch, Ministry of Transportation of Ontario, Toronto, Ontario, Canada. Electronic address: justin.chee@mail.utoronto.ca.

Chris Simpson (C)

Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada.

Robert S Sheldon (RS)

Libin Cardiovascular Institute of Alberta, Department of Cardiac Sciences, University of Calgary, Health Research Innovation Centre, Calgary, Alberta, Canada.

Paul Dorian (P)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; St Michael's Hospital, Toronto, Ontario, Canada.

Jamie Dow (J)

Société de l'assurance Automobile du Québec, Québec, Québec, Canada.

Juan Guzman (J)

Department of Medicine, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.

Satish R Raj (SR)

Libin Cardiovascular Institute of Alberta, Department of Cardiac Sciences, University of Calgary, Health Research Innovation Centre, Calgary, Alberta, Canada.

Roopinder K Sandhu (RK)

Division of Cardiology, Walter C. MacKenzie Health Sciences Centre, University of Alberta, Edmonton, Alberta, Canada.

Venkatesh Thiruganasambandamoorthy (V)

Ottawa Hospital Research Institute, Department of Emergency Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Martin S Green (MS)

Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.

Andrew D Krahn (AD)

Heart Rhythm Vancouver, Division of Cardiology, Department of Medicine, Gordon & Leslie Diamond Health Care Centre, University of British Columbia, Vancouver, British Columbia, Canada.

Sarah Plonka (S)

Safety Program Development Branch, Ministry of Transportation of Ontario, Toronto, Ontario, Canada.

Mark J Rapoport (MJ)

Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH